Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUFOX: Curcumin with FOLFOX in Inoperable Colorectal Cancer
NCT01490996Phase 2Completed
- Sponsor
- University of Leicester
- Start
- Feb 2012
- Primary completion
- May 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in colorectal cancer (CRC), sponsored by University of Leicester. Started Feb 2012; status: completed.
02
Drugs
curcumin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01490996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490996.